Edward Gaynor
-
- Pharmaceutical studies and practices 3
-
- SARS-CoV-2 and COVID-19 Research 1
-
- Autoimmune and Inflammatory Disorders Research 2
-
- Acute Lymphoblastic Leukemia research 2
-
- Glycosylation and Glycoproteins Research 1
-
- Genomics and Rare Diseases 1
-
- Gastrointestinal motility and disorders 1
-
- Eosinophilic Esophagitis 1
Edward Gaynor
9 papers receiving 96 citations
Peers
Comparison fields: 5 of 47
- Pediatrics, Perinatology and Child Health 35
- Infectious Diseases 25
- Emergency Medicine 9
- Physiology 24
- Obstetrics and Gynecology 7
Countries citing papers authored by Edward Gaynor
This map shows the geographic impact of Edward Gaynor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward Gaynor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward Gaynor more than expected).
Fields of papers citing papers by Edward Gaynor
This network shows the impact of papers produced by Edward Gaynor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward Gaynor. The network helps show where Edward Gaynor may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Edward Gaynor, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 0 | |
| 5 | 2023 | 1 | |
| 6 | 2022 | 0 | |
| 7 | 2021 | 6 | |
| 8 | 2021 | 46 | |
| 9 | 2021 | 1 | |
| 10 | 2015 | 40 | |
| 11 | 2015 | 1 | |
| 12 | 2013 | 2 |
About Edward Gaynor
Edward Gaynor is a scholar working on Hematology, Pediatrics, Perinatology and Child Health, Gastroenterology, Speech and Hearing and Emergency Medical Services, having authored 12 papers that have together received 99 indexed citations. Recurring topics across this work include Pharmaceutical studies and practices (3 papers), Autoimmune and Inflammatory Disorders Research (2 papers), Acute Lymphoblastic Leukemia research (2 papers), Glycosylation and Glycoproteins Research (1 paper), Genomics and Rare Diseases (1 paper), SARS-CoV-2 and COVID-19 Research (1 paper), Gastrointestinal motility and disorders (1 paper) and Eosinophilic Esophagitis (1 paper). The work is most often cited by research in Pediatrics, Perinatology and Child Health (35 citations), Infectious Diseases (25 citations), Emergency Medicine (9 citations), Physiology (24 citations) and Obstetrics and Gynecology (7 citations). Edward Gaynor has collaborated with scholars based in United Kingdom, Italy and Australia. Frequent co-authors include Peter Sullivan, Fevronia Kiparissi, Osvaldo Borrelli, Anna Rybak, Lucy Howarth, Pamela Sullivan, Alistair Calder, Antonia Dastamani, Enrico Felici and Anwar T. Merchant. Their work appears in journals such as Archives of Disease in Childhood, Radiology, Frontiers in Pediatrics, Alimentary Pharmacology & Therapeutics and Clinical and Translational Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.